To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AKAP13TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
418 representative clones for gene AKAP13 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AI742384 pooled .a 1 to 495 496 to 1   tiling clone,   496/496
(100 %)
1 diff
(99.8 %id)
NM_006738.4   .a 448 to 13749 1 to 13302 exact RefSeq,   13302/13302
(100 %)
0 diff
(100 %id)
AF406992   .a 537 to 10004 1 to 9468 D619A G624V V897M G2461S tiling clone,   9468/9468
(100 %)
12 diff
(99.9 %id)
NM_007200.3   .b 1 to 13290 1 to 13290 exact RefSeq,   13290/13290
(100 %)
0 diff
(100 %id)
AB055890 lung .b 78 to 10093 121 to 10136 M452T W494R R574C E689K V845A ... tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 10016/10136
(98 %)
28 diff
(99.8 %id)
AA814393 germinal center B cell .b 98 to 833 1 to 733     Submitted on the opposite strand 733/985
(74 %)
8 diff
(99.2 %id)
N92982 lung .b 117 to 318 1 to 202     Submitted on the opposite strand 202/202
(100 %)
0 diff
(100 %id)
AF387101   .b 171 to 8612 1 to 8442 G191R C354R R574C A609V A614T ... tiling clone,   8442/8442
(100 %)
11 diff
(99.9 %id)
BG531262 embryonal carcinoma, testis .b 250 to 994 1 to 747       747/747
(100 %)
8 diff
(99.0 %id)
DA460844 tongue, tumor tissue .b 783 to 1354 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA834423 placenta .b 1004 to 1785 2 to 785   capped   784/784
(100 %)
8 diff
(99.0 %id)
BQ706176 Spleen .b 1152 to 1887 1 to 737       737/979
(75 %)
10 diff
(99.0 %id)
AL708859 human skeletal muscle .b 1374 to 1832 1 to 459   tiling clone,   459/459
(100 %)
1 diff
(99.8 %id)
CF593455 Human Placenta, placenta .b 1789 to 2562 25 to 798   tiling clone,   774/798
(96 %)
6 diff
(99.3 %id)
BQ220245 embryonal carcinoma, cell line, testis .b 1845 to 2703 1 to 858       858/860
(99 %)
5 diff
(99.5 %id)
CK000835 mixed .b 1864 to 2683 1 to 818       818/818
(100 %)
13 diff
(98.5 %id)
CN403631 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1972 to 2680 1 to 710       710/710
(100 %)
4 diff
(99.5 %id)
BI225986 Burkitt lymphoma, lymph .b 2100 to 2923 1 to 837       837/995
(84 %)
41 diff
(95.9 %id)
TI_154157985   .b 2139 to 2672 87 to 620       534/534
(100 %)
1 diff
(99.9 %id)
M90360 thyroid gland .b 2430 to 5460 1 to 3031   AAA   3031/3031
(100 %)
3 diff
(100.0 %id)
BX951014   .b 2653 to 3355 1 to 703       703/703
(100 %)
1 diff
(99.9 %id)
DB222351 trachea .b 2824 to 3397 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
BI053829 placenta_normal .b 3049 to 3496 446 to 1       446/446
(100 %)
8 diff
(98.3 %id)
FN068089 breast carcinoma .b 3545 to 3646 100 to 1     Submitted on the opposite strand 100/100
(100 %)
5 diff
(95.0 %id)
BQ061949 lymph, lymphoma, cell line .b 3750 to 4634 1 to 891       891/1000
(89 %)
16 diff
(98.4 %id)
BG326121 Kidney, renal cell adenocarcinoma .b 3883 to 4648 1 to 767       767/1034
(74 %)
21 diff
(98.0 %id)
AL135046 melanoma (MeWo cell line) .b 4048 to 4691 1 to 644       644/644
(100 %)
0 diff
(100 %id)
DA459610 tongue, tumor tissue .b 4188 to 4666 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
BI020255 marrow .b 4220 to 4633 1 to 414       414/414
(100 %)
0 diff
(100 %id)
BG389457 embryonal carcinoma, cell line, testis .b 4329 to 4983 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
N41697 placenta .b 4334 to 4400 1 to 67       67/67
(100 %)
0 diff
(100 %id)
BQ939948 leiomyosarcoma, uterus .b 4591 to 5437 850 to 1     Submitted on the opposite strand 850/856
(99 %)
12 diff
(98.6 %id)
AI797853 B-cell, chronic lymphotic leukemia .b 4666 to 5457 786 to 1       786/788
(99 %)
22 diff
(97.3 %id)
BF593635 brain, glioblastoma (pooled) .b 4884 to 5456 573 to 1       573/573
(100 %)
0 diff
(100 %id)
BU753842 placenta .b 4987 to 5456 488 to 19   AAA   470/470
(100 %)
0 diff
(100 %id)
AW206600   .b 5008 to 5460 470 to 18   AAA   453/453
(100 %)
0 diff
(100 %id)
AI357731 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 5031 to 5456 426 to 1       426/426
(100 %)
0 diff
(100 %id)
BC089394 Lymph, normal germinal center B cells .b 5036 to 5456 1 to 421   AAA   421/421
(100 %)
0 diff
(100 %id)
DB314542 tongue, tumor tissue .b 5093 to 5513 421 to 1       421/423
(99 %)
1 diff
(99.8 %id)
BC063592 Testis, embryonal carcinoma .b 5190 to 8511 1 to 3322   tiling clone, available from MGC, AAA   3322/3322
(100 %)
0 diff
(100 %id)
BG390043 embryonal carcinoma, cell line, testis .b 5190 to 5905 1 to 718   available from MGC,   718/880
(81 %)
5 diff
(99.5 %id)
TI_154166195   .b 5240 to 5713 80 to 553       474/474
(100 %)
0 diff
(100 %id)
TI_2194698019   .b 5348 to 6150 804 to 1       804/1245
(64 %)
4 diff
(99.7 %id)
BC040109 Uterus, leiomyosarcoma .b 5396 to 7215 1 to 1820   available from MGC, AAA   1820/1820
(100 %)
0 diff
(100 %id)
BM463611 leiomyosarcoma, uterus .b 5396 to 6421 1 to 1033   available from MGC,   1033/1042
(99 %)
23 diff
(97.8 %id)
BF508954   .b 5753 to 6124 389 to 18   AAA   372/375
(99 %)
3 diff
(99.2 %id)
BE397707 Burkitt lymphoma, lymph .b 6012 to 6742 20 to 745       726/781
(92 %)
13 diff
(98.4 %id)
BE562162 Burkitt lymphoma, lymph .b 6018 to 6757 46 to 798       748/970
(77 %)
20 diff
(98.0 %id)
TI_2016725989   .b 6019 to 7179 1165 to 20       1146/1305
(87 %)
21 diff
(98.4 %id)
TI_2194698178   .b 6019 to 7095 1076 to 5       1072/1290
(83 %)
6 diff
(99.6 %id)
BF905946 marrow .b 6308 to 6505 1 to 198       198/198
(100 %)
0 diff
(100 %id)
TI_2194698032   .b 6491 to 7619 9 to 1127       1119/1273
(87 %)
30 diff
(97.7 %id)
TI_2016725985   .b 6539 to 7683 1153 to 19       1135/1275
(89 %)
32 diff
(97.5 %id)
TI_2016726431   .b 6563 to 7638 1 to 1070       1070/1236
(86 %)
15 diff
(98.8 %id)
TI_2194698170   .b 6587 to 7681 1098 to 10       1089/1283
(84 %)
8 diff
(99.4 %id)
TI_2194698119   .b 6623 to 7683 1075 to 18       1058/1245
(84 %)
4 diff
(99.7 %id)
BE816289 breast_normal .b 6665 to 6837 1 to 173       173/173
(100 %)
0 diff
(100 %id)
BG391768 embryonal carcinoma, cell line, testis .b 6684 to 7453 1 to 765       765/971
(78 %)
23 diff
(97.7 %id)
BE816233 breast_normal .b 6688 to 7179 1 to 492       492/492
(100 %)
0 diff
(100 %id)
BE816243 breast_normal .b 6735 to 7010 1 to 276       276/276
(100 %)
0 diff
(100 %id)
TI_2194698049   .b 6980 to 8169 8 to 1181       1174/1270
(92 %)
29 diff
(97.8 %id)
TI_2194697981   .b 6992 to 8175 26 to 1203       1178/1304
(90 %)
24 diff
(98.2 %id)
TI_2194698116   .b 7024 to 8202 1169 to 4       1166/1266
(92 %)
17 diff
(98.7 %id)
BI862503 breast, mammary adenocarcinoma, cell line .b 7059 to 7871 1 to 814       814/818
(99 %)
8 diff
(99.1 %id)
TI_57192679   .b 7059 to 7871 111 to 924       814/818
(99 %)
8 diff
(99.1 %id)
BM917432 blood, natural killer cells, cell line .b 7061 to 7891 1 to 833       833/1104
(75 %)
10 diff
(99.1 %id)
BX384042   .b 7174 to 8161 1 to 982       982/982
(100 %)
12 diff
(98.8 %id)
TI_2016725947   .b 7182 to 8198 1025 to 12       1014/1270
(79 %)
13 diff
(99.0 %id)
TI_2194698000   .b 7274 to 8417 1 to 1136       1136/1296
(87 %)
42 diff
(96.8 %id)
TI_2194698072   .b 7279 to 8383 1 to 1093       1093/1250
(87 %)
18 diff
(98.6 %id)
BE269948 Burkitt lymphoma, lymph .b 7381 to 8099 1 to 717       717/751
(95 %)
20 diff
(97.4 %id)
BQ642903 lymph, lymphoma, cell line .b 7381 to 8224 1 to 856       856/916
(93 %)
36 diff
(96.1 %id)
CX755258 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 7447 to 8228 1 to 774     Submitted on the opposite strand 774/786
(98 %)
20 diff
(97.5 %id)
TI_2194698103   .b 7457 to 8564 1108 to 5       1103/1246
(88 %)
9 diff
(99.3 %id)
BM706688 eye, optic nerve .b 7562 to 8141 1 to 580   fully sequenced,   580/580
(100 %)
5 diff
(99.2 %id)
AA112427 Pancreas .b 7601 to 7958 1 to 359       359/359
(100 %)
2 diff
(99.5 %id)
BU167775 eye, retinoblastoma .b 7612 to 8517 1 to 910       910/912
(99 %)
15 diff
(98.4 %id)
TI_2194698120   .b 7625 to 8667 1054 to 14       1041/1238
(84 %)
9 diff
(99.3 %id)
TI_227715518   .b 7683 to 8544 909 to 61       849/1051
(80 %)
16 diff
(98.5 %id)
TI_154097851   .b 7726 to 8522 875 to 85   AAA   791/796
(99 %)
10 diff
(98.8 %id)
BQ058403 lymph, lymphoma, cell line .b 7751 to 8525 1 to 777       777/777
(100 %)
3 diff
(99.7 %id)
BQ009112 Chondrosarcoma, Left Pubic Bone .b 7764 to 8522 772 to 17   AAA   756/756
(100 %)
4 diff
(99.5 %id)
CA440772 lung, Metastatic Chondrosarcoma .b 7792 to 8522 742 to 17   AAA   726/726
(100 %)
6 diff
(99.2 %id)
BQ378395 uterus_tumor .b 7797 to 7888 110 to 19       92/110
(83 %)
0 diff
(100 %id)
CA445761 Chondrosarcoma, Left Pubic Bone .b 7829 to 8522 709 to 17   AAA   693/693
(100 %)
2 diff
(99.8 %id)
CD366648 Alveolar Macrophage, lung .b 7829 to 8520 705 to 16   AAA   690/690
(100 %)
2 diff
(99.8 %id)
TI_2194698077   .b 7838 to 9064 16 to 1231       1216/1281
(94 %)
28 diff
(97.9 %id)
TI_2016725931   .b 7929 to 9130 1205 to 19   tiling clone,   1187/1279
(92 %)
7 diff
(99.5 %id)
BX348609   .b 7958 to 8887 1 to 931       931/931
(100 %)
12 diff
(98.8 %id)
TI_2194698121   .b 8034 to 9224 1187 to 5       1183/1245
(95 %)
16 diff
(98.8 %id)
TI_2016725987   .b 8081 to 9223 1145 to 7       1139/1261
(90 %)
7 diff
(99.5 %id)
BU728083 eye, optic nerve .b 8111 to 8522 430 to 19   fully sequenced, AAA   412/412
(100 %)
0 diff
(100 %id)
AI364656 B-cell, chronic lymphotic leukemia .b 8248 to 8511 264 to 1       264/264
(100 %)
0 diff
(100 %id)
AI565363 Kidney .b 8281 to 8523 243 to 1       243/243
(100 %)
0 diff
(100 %id)
TI_149283032   .b 8533 to 9352 896 to 86   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 811/812
(99 %)
24 diff
(97.1 %id)
TI_2194698079   .b 8569 to 9694 1123 to 6       1118/1234
(90 %)
0 diff
(100 %id)
BM458005 leiomyosarcoma, uterus .b 8797 to 9480 1 to 689       689/1254
(54 %)
18 diff
(98.6 %id)
TI_2194698073   .b 8849 to 10004 1143 to 4       1140/1278
(89 %)
0 diff
(100 %id)
AL133426   .b 8881 to 10093 1 to 1213   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1213/1213
(100 %)
2 diff
(99.9 %id)
DA570418 whole embryo, mainly head .b 8946 to 9628 2 to 681   tiling clone, fully sequenced, capped   680/680
(100 %)
2 diff
(99.8 %id)
TI_2194698102   .b 8964 to 10005 1 to 1038       1038/1238
(83 %)
15 diff
(98.8 %id)
TI_2194698115   .b 9282 to 10301 8 to 1022       1015/1216
(83 %)
12 diff
(99.1 %id)
DA189477 amygdala .b 9303 to 9874 2 to 573   tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
TI_2194698114   .b 9316 to 10485 1163 to 7       1157/1254
(92 %)
0 diff
(100 %id)
BQ777050 Pancreas, Purified pancreatic islet .b 9355 to 9793 2 to 440   fully sequenced,   439/440
(99 %)
7 diff
(98.5 %id)
CN403630 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 9514 to 9910 1 to 397       397/397
(100 %)
0 diff
(100 %id)
TI_154167889   .b 9536 to 10210 798 to 117     Submitted on the opposite strand 682/874
(78 %)
0 diff
(100 %id)
DB357186 whole embryo, mainly head .b 9598 to 10093 497 to 1   fully sequenced,   497/497
(100 %)
3 diff
(99.4 %id)
AI674926 adenocarcinoma, Pancreas .b 9612 to 10095 484 to 1       484/484
(100 %)
0 diff
(100 %id)
Z18819   .b 9613 to 9905 292 to 1       292/292
(100 %)
3 diff
(99.0 %id)
AI095735 uterus .b 9616 to 10093 478 to 1       478/478
(100 %)
0 diff
(100 %id)
BF196330 fibrotheoma, ovary .b 9623 to 10093 471 to 1       471/471
(100 %)
0 diff
(100 %id)
AW276571 lung, two pooled squamous cell carcinomas .b 9640 to 10093 454 to 1       454/454
(100 %)
0 diff
(100 %id)
BF992498 placenta_normal .b 9664 to 10037 377 to 4       374/377
(99 %)
0 diff
(100 %id)
AA113166 Pancreas .b 9668 to 10093 428 to 1       428/429
(99 %)
3 diff
(99.4 %id)
CF138117 lymph .b 9672 to 10210 568 to 30     Submitted on the opposite strand 539/568
(94 %)
0 diff
(100 %id)
BF989719 placenta_normal .b 9691 to 10037 350 to 4       347/350
(99 %)
0 diff
(100 %id)
BU430665 lymph .b 9715 to 10173 8 to 466     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 459/466
(98 %)
6 diff
(98.8 %id)
AI921278 adenocarcinoma, Pancreas .b 9745 to 10128 384 to 1       384/384
(100 %)
0 diff
(100 %id)
BU069314 Pancreas, Purified pancreatic islet .b 9763 to 10092 330 to 1   fully sequenced,   330/330
(100 %)
1 diff
(99.7 %id)
DB227043 trachea .b 9788 to 10368 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
TI_154173945   .b 9793 to 10635 93 to 959       867/1166
(74 %)
56 diff
(95.2 %id)
TI_2194698101   .b 9832 to 10976 1142 to 10       1133/1268
(89 %)
0 diff
(100 %id)
TI_2194698075   .b 9851 to 10881 18 to 1047       1030/1047
(98 %)
6 diff
(99.5 %id)
AL135297 melanoma (MeWo cell line) .b 9859 to 10681 1 to 824   tiling clone,   824/824
(100 %)
1 diff
(99.9 %id)
C75484   .b 9895 to 10100 209 to 3       207/209
(99 %)
0 diff
(100 %id)
DA165525 amygdala .b 9919 to 10514 2 to 597   capped   596/596
(100 %)
0 diff
(100 %id)
TI_154164919   .b 9964 to 10803 76 to 908       833/928
(89 %)
12 diff
(98.8 %id)
DA861730 placenta .b 10020 to 10572 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
TI_154160524   .b 10099 to 10799 80 to 769       690/697
(98 %)
24 diff
(96.6 %id)
DA927858 small intestine .b 10108 to 10679 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA594762 lung .b 10124 to 10696 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA723442   .b 10125 to 10689 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB122083 thymus .b 10126 to 10681 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AK091210 tongue, tumor tissue .b 10134 to 13290 1 to 3152   tiling clone, available from FLJ,   3152/3152
(100 %)
10 diff
(99.7 %id)
DA439370 tongue, tumor tissue .b 10135 to 10729 2 to 596   capped   595/595
(100 %)
2 diff
(99.7 %id)
AW889382 nervous_tumor .b 10165 to 10471 1 to 307       307/307
(100 %)
0 diff
(100 %id)
AA312928   .b 10180 to 10426 1 to 247       247/247
(100 %)
0 diff
(100 %id)
DA757215   .b 10218 to 10771 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BM451990 eye, retinoblastoma .b 10245 to 10993 1 to 751       751/937
(80 %)
10 diff
(99.0 %id)
DA289075 hippocampus .b 10248 to 10653 2 to 407   capped   406/406
(100 %)
0 diff
(100 %id)
DA386916 thalamus .b 10341 to 10909 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA619609   .b 10343 to 10905 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA389225 thalamus .b 10370 to 10945 2 to 577   tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
TI_2194698080   .b 10462 to 11576 1 to 1109       1109/1259
(88 %)
11 diff
(99.2 %id)
DA646184 mammary gland .b 10566 to 11315 2 to 750   capped   749/759
(98 %)
9 diff
(98.9 %id)
TI_2016725983   .b 10598 to 11728 1131 to 7       1125/1254
(89 %)
0 diff
(100 %id)
TI_2194698118   .b 10638 to 11729 1089 to 7       1083/1231
(87 %)
0 diff
(100 %id)
CA405805 adipose .b 10643 to 10996 1 to 354       354/354
(100 %)
0 diff
(100 %id)
BQ049689 lymph, lymphoma, cell line .b 10734 to 11648 1 to 919       919/1031
(89 %)
21 diff
(98.0 %id)
BQ707281 Spleen .b 10740 to 11567 1 to 840       840/1033
(81 %)
26 diff
(97.5 %id)
BM785632 Ascites, stomach .b 10863 to 11496 1 to 634       634/634
(100 %)
0 diff
(100 %id)
DA932604 Spleen .b 10873 to 11439 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
DB273466 uterus .b 10957 to 11216 2 to 261   capped   260/260
(100 %)
0 diff
(100 %id)
DA940879 Spleen .b 10983 to 11564 2 to 583   capped   582/582
(100 %)
0 diff
(100 %id)
BI489860 pooled brain, lung, testis .b 11032 to 11791 1 to 759       759/760
(99 %)
6 diff
(99.3 %id)
TI_2016725957   .b 11089 to 12193 1114 to 18       1097/1253
(87 %)
0 diff
(100 %id)
BP422496 small intestine .b 11188 to 11712 1 to 525     Submitted on the opposite strand 525/525
(100 %)
0 diff
(100 %id)
AL133430   .b 11205 to 13285 1 to 2081   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 2081/2081
(100 %)
2 diff
(100.0 %id)
BX101032 liver and spleen .b 11205 to 11904 1 to 700       700/700
(100 %)
0 diff
(100 %id)
BM564498 blood, natural killer cells, cell line .b 11255 to 11971 1 to 724       724/1188
(60 %)
20 diff
(98.4 %id)
BG292387 bladder, transitional cell papilloma, cell line .b 11319 to 12062 1 to 738       738/841
(87 %)
15 diff
(98.3 %id)
AL133429   .b 11365 to 13290 1 to 1926   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1926/1926
(100 %)
3 diff
(99.9 %id)
BX952535   .b 11373 to 11954 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_2194699553   .b 11378 to 12434 1148 to 111       1038/1258
(82 %)
0 diff
(100 %id)
TI_2194695904   .b 11396 to 12434 1131 to 109       1023/1252
(81 %)
0 diff
(100 %id)
TI_2194698104   .b 11478 to 12434 12 to 969       958/1261
(75 %)
4 diff
(99.7 %id)
DA568737 whole embryo, mainly head .b 11576 to 12343 2 to 768   capped   767/767
(100 %)
4 diff
(99.5 %id)
BM796834 Ascites, stomach .b 11613 to 12137 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CR596185 Placenta Cot 25-normalized .b 11676 to 13292 1 to 1617   tiling clone,   1617/1617
(100 %)
0 diff
(100 %id)
AL549001 placenta, Placenta Cot 25-normalized .b 11676 to 12659 1 to 978       978/982
(99 %)
8 diff
(99.2 %id)
BG479012 choriocarcinoma, placenta .b 11754 to 12447 1 to 695       695/695
(100 %)
7 diff
(99.0 %id)
BE907767 epithelioid carcinoma, Pancreas .b 11772 to 12551 1 to 787       787/970
(81 %)
34 diff
(96.5 %id)
BM903586 ovary (pool of 3) .b 11842 to 12708 15 to 889       875/1103
(79 %)
19 diff
(98.3 %id)
BI913427 brain .b 11893 to 12760 1 to 869       869/869
(100 %)
17 diff
(98.1 %id)
BG259833 bladder, transitional cell papilloma, cell line .b 11936 to 12731 1 to 812       812/890
(91 %)
34 diff
(96.2 %id)
BM705133 eye, RPE and Choroid .b 11959 to 12184 1 to 226     Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 226/228
(99 %)
1 diff
(99.6 %id)
BC019662 Bladder, transitional cell papilloma .b 12061 to 13290 1 to 1230   available from MGC, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 1230/1230
(100 %)
3 diff
(99.8 %id)
BI223661 cervical carcinoma cell line, cervix .b 12123 to 12854 1 to 730       730/730
(100 %)
7 diff
(99.1 %id)
BU182343 eye, retinoblastoma .b 12146 to 12943 1 to 806       806/905
(89 %)
15 diff
(98.4 %id)
BG120405 adenocarcinoma, cell line, Liver .b 12182 to 12926 1 to 737       737/861
(85 %)
26 diff
(97.0 %id)
TI_159705942   .b 12194 to 13091 923 to 37       887/1049
(84 %)
0 diff
(100 %id)
BG285556 bladder, transitional cell papilloma, cell line .b 12278 to 13047 1 to 763       763/766
(99 %)
14 diff
(98.2 %id)
TI_149299421   .b 12287 to 13290 1073 to 90   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 984/1017
(96 %)
28 diff
(97.3 %id)
CF457288 peripheral nervous system .b 12382 to 13089 1 to 704       704/714
(98 %)
6 diff
(99.2 %id)
TI_154126181   .b 12494 to 13290 887 to 101   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 787/789
(99 %)
24 diff
(97.0 %id)
CB850757 lung, Primary Lung Cystic Fibrosis EpithelialCells .b 12566 to 13290 737 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 719/719
(100 %)
7 diff
(99.1 %id)
BQ576159 Chondrosarcoma Grade II, Left Pelvis .b 12572 to 13293 737 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 719/721
(99 %)
5 diff
(99.4 %id)
BQ573989 Chondrosarcoma Grade II, Left Pelvis .b 12575 to 13292 732 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 714/714
(100 %)
7 diff
(99.1 %id)
BU623555 cell lines, Enchondroma .b 12578 to 13290 729 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 711/711
(100 %)
4 diff
(99.5 %id)
AW575773 lymph .b 12588 to 13090 520 to 18   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 503/503
(100 %)
2 diff
(99.7 %id)
CA306665 Alveolar Macrophage, lung .b 12588 to 13293 724 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 706/708
(99 %)
4 diff
(99.5 %id)
CA411617 Knee, Osteoarthritic Cartilage .b 12603 to 13290 706 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 688/688
(100 %)
0 diff
(100 %id)
CA422166 Bone, Enchondroma cell line .b 12603 to 13292 705 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 687/693
(99 %)
6 diff
(99.2 %id)
BM707378 eye, eye anterior segment .b 12625 to 12948 9 to 332   fully sequenced, Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 324/332
(97 %)
1 diff
(99.7 %id)
BM663933 eye, RPE and Choroid .b 12672 to 13291 639 to 19   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 621/621
(100 %)
3 diff
(99.6 %id)
AI205229 brain, meningioma .b 12677 to 13076 400 to 1       400/400
(100 %)
0 diff
(100 %id)
DB313593 tongue, tumor tissue .b 12754 to 13290 533 to 1       533/533
(100 %)
6 diff
(98.9 %id)
DB332593 Spleen .b 12767 to 13284 519 to 2       518/519
(99 %)
0 diff
(100 %id)
BM673486 eye, eye anterior segment .b 12918 to 13290 391 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 373/373
(100 %)
1 diff
(99.8 %id)
AK125331   .c 1 to 5459 2 to 5460   tiling clone, available from FLJ,   5460/5460
(100 %)
18 diff
(99.7 %id)
DA725938   .c 1 to 570 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA720641   .c 16 to 581 2 to 567   tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
BP871581 embryonal kidney .c 17 to 610 1 to 595       595/596
(99 %)
4 diff
(99.4 %id)
DA457807 tongue, tumor tissue .c 20 to 608 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
DA759553   .c 20 to 567 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BI550257 brain, hippocampus .c 48 to 690 1 to 645   available from MGC,   645/645
(100 %)
20 diff
(96.9 %id)
TI_44169464   .c 49 to 690 89 to 732       644/732
(87 %)
23 diff
(96.9 %id)
AA651894 germinal center B cell .c 161 to 614 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
AA769382 germinal center B cell .c 161 to 595 1 to 435     Submitted on the opposite strand 435/435
(100 %)
0 diff
(100 %id)
AA826103 germinal center B cell .c 161 to 496 1 to 336     Submitted on the opposite strand 336/336
(100 %)
0 diff
(100 %id)
AA825622 germinal center B cell .c 161 to 588 1 to 428     Submitted on the opposite strand 428/428
(100 %)
0 diff
(100 %id)
AA291257 germinal center B cell .c 163 to 553 1 to 391     Submitted on the opposite strand 391/391
(100 %)
0 diff
(100 %id)
AI762936 B-cell, chronic lymphotic leukemia .c 169 to 619 1 to 451     Submitted on the opposite strand 451/451
(100 %)
6 diff
(98.7 %id)
AI523602 B-cell, chronic lymphotic leukemia .c 170 to 629 1 to 460     Submitted on the opposite strand 460/460
(100 %)
2 diff
(99.6 %id)
AI523593 B-cell, chronic lymphotic leukemia .c 170 to 644 1 to 474     Submitted on the opposite strand 474/474
(100 %)
3 diff
(99.4 %id)
AA482036 germinal center B cell .c 208 to 665 1 to 458     Submitted on the opposite strand 458/458
(100 %)
0 diff
(100 %id)
BC009213 Lymph, Burkitt lymphoma .c 2154 to 5458 1 to 3305   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 3305/3327
(99 %)
11 diff
(99.7 %id)
BC000269 Eye, retinoblastoma .c 2833 to 5458 1 to 2626   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2626/2643
(99 %)
10 diff
(99.7 %id)
AK026186   .c 3492 to 5458 1 to 1967   available from FLJ, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 1967/1981
(99 %)
7 diff
(99.7 %id)
BQ214042 melanotic melanoma, skin .c 4353 to 5211 1 to 859       859/859
(100 %)
5 diff
(99.5 %id)
BM413651 eye, retinoblastoma .c 4576 to 5267 11 to 704       694/956
(72 %)
8 diff
(99.2 %id)
AB209414 brain .c 4677 to 10086 1 to 5410   tiling clone,   5410/5410
(100 %)
8 diff
(99.9 %id)
BE269760 Burkitt lymphoma, lymph .c 4736 to 5256 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
T04926   .c 4740 to 5007 268 to 1       268/268
(100 %)
3 diff
(98.9 %id)
DB324371   .c 4879 to 5459 581 to 1       581/581
(100 %)
1 diff
(99.9 %id)
TI_2016724885   .c 5347 to 6170 105 to 928     Submitted on the opposite strand 824/1285
(64 %)
14 diff
(99.0 %id)
TI_2194697961   .c 5347 to 6158 817 to 3       815/1309
(62 %)
0 diff
(100 %id)
TI_2194699175   .c 5347 to 6487 83 to 1205       1123/1277
(87 %)
24 diff
(98.2 %id)
BC140862 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .c 5347 to 12427 1 to 7082   tiling clone,   7082/7082
(100 %)
11 diff
(99.9 %id)
BC171798 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .c 5347 to 12426 1 to 7081   tiling clone,   7081/7081
(100 %)
11 diff
(99.9 %id)
TI_2194698005   .c 5383 to 6624 1221 to 3       1179/1266
(93 %)
25 diff
(98.1 %id)
TI_2194697951   .c 5399 to 6618 1217 to 10       1208/1280
(94 %)
16 diff
(98.8 %id)
BU189677 melanotic melanoma, skin .c 5534 to 6365 19 to 858       840/858
(97 %)
27 diff
(96.9 %id)
AA768121 germinal center B cell .c 5683 to 6075 393 to 1       393/393
(100 %)
0 diff
(100 %id)
AW601890 breast .c 5718 to 6308 603 to 14       590/605
(97 %)
1 diff
(99.9 %id)
BF311274 brain, neuroblastoma .c 5775 to 6438 1 to 655       655/933
(70 %)
16 diff
(98.3 %id)
BC017368 Brain, neuroblastoma .c 5776 to 8499 1 to 2725   tiling clone, available from MGC, AAA   2725/2725
(100 %)
1 diff
(100.0 %id)
AA939219 pooled .c 5784 to 6125 342 to 1       342/342
(100 %)
0 diff
(100 %id)
BE261016 brain, neuroblastoma .c 5795 to 6349 1 to 555       555/555
(100 %)
0 diff
(100 %id)
BE262216 brain, neuroblastoma .c 5795 to 6371 1 to 577   available from MGC,   577/577
(100 %)
0 diff
(100 %id)
TI_2194698125   .c 5856 to 7013 1 to 1147       1152/1273
(90 %)
20 diff
(98.5 %id)
TI_2016725949   .c 5857 to 6908 3 to 1047       1045/1264
(82 %)
14 diff
(98.9 %id)
U03634   .c 5895 to 7176 222 to 1503       1282/1737
(73 %)
12 diff
(99.4 %id)
TI_2194698123   .c 5957 to 7172 1214 to 19       1196/1281
(93 %)
24 diff
(98.2 %id)
DB094621 testis .d 1 to 546 2 to 548   tiling clone, capped   547/547
(100 %)
2 diff
(99.7 %id)
AF126008 testis .d 374 to 4663 1 to 4290 V651D G1073S D1104G E1230D R1231G ... tiling clone,   4290/4290
(100 %)
8 diff
(99.9 %id)
NM_144767.3   .e 1 to 8081 1 to 8081 exact RefSeq,   8081/8081
(100 %)
0 diff
(100 %id)
AF127481 skeletal muscle .f 1 to 4330 1 to 4340 C140W A141C N142K C143L S144Q ... tiling clone,   4340/4991
(86 %)
18 diff
(99.7 %id)
DC353777 brain .g 1 to 606 1 to 607   tiling clone,   607/607
(100 %)
1 diff
(99.9 %id)
DC422240 uterus .g 65 to 621 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
DC398288 testis .g 71 to 633 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
DC327033 caudate nucleus .g 78 to 561 1 to 479       479/479
(100 %)
2 diff
(99.6 %id)
DC340237 thalamus .g 78 to 657 1 to 580   tiling clone,   580/580
(100 %)
2 diff
(99.7 %id)
DC324052 brain .g 87 to 686 1 to 601       601/601
(100 %)
2 diff
(99.7 %id)
AA332470 Embryo, 8 weeks .g 102 to 350 1 to 250       250/251
(99 %)
2 diff
(99.3 %id)
AK315885 whole embryo, mainly head .g 346 to 1897 1 to 1552   tiling clone,   1552/1552
(100 %)
1 diff
(100.0 %id)
DC424051 whole embryo, mainly head .g 346 to 1126 1 to 782       782/785
(99 %)
4 diff
(99.5 %id)
CB267714 adipose .g 600 to 1254 1 to 656       656/656
(100 %)
10 diff
(98.5 %id)
AK309805 brain .g 731 to 3642 1 to 2912 E76G P480L M645L T829I tiling clone,   2912/2912
(100 %)
4 diff
(99.9 %id)
DC376108 brain .g 731 to 1293 1 to 563       563/563
(100 %)
1 diff
(99.9 %id)
BM794971 Ascites, stomach .g 1133 to 1786 1 to 654       654/654
(100 %)
1 diff
(99.9 %id)
AW340377 pooled .g 1201 to 1893 693 to 1       693/693
(100 %)
7 diff
(99.0 %id)
AI953197 anaplastic oligodendroglioma, brain .g 1221 to 1896 682 to 8       675/693
(97 %)
17 diff
(97.6 %id)
DC426071 brain .g 1327 to 1884 561 to 1       561/561
(100 %)
3 diff
(99.5 %id)
AA653371   .g 1347 to 1893 545 to 1       545/546
(99 %)
4 diff
(99.3 %id)
BF435045 fibrotheoma, ovary .g 1359 to 1893 535 to 1       535/535
(100 %)
0 diff
(100 %id)
AF086293 heart .g 1369 to 1896 1 to 528   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 528/528
(100 %)
1 diff
(99.9 %id)
W70073 heart .g 1678 to 1893 217 to 1   fully sequenced, Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 217/217
(100 %)
1 diff
(99.6 %id)
BM910779 astrocytoma grade IV, cell line, brain .h 1 to 823 1 to 822   tiling clone,   822/1073
(76 %)
9 diff
(99.2 %id)
AI692987 pooled .h 280 to 1014 732 to 1       732/732
(100 %)
14 diff
(98.1 %id)
AW195587 pooled .h 318 to 1014 696 to 1       696/763
(91 %)
14 diff
(98.2 %id)
BF998197 placenta_normal .h 355 to 921 1 to 566       566/566
(100 %)
13 diff
(97.8 %id)
AA906063 pooled .h 439 to 1014 576 to 1       576/576
(100 %)
2 diff
(99.7 %id)
AW572582 adenocarcinoma, Pancreas .h 442 to 1014 569 to 1   tiling clone,   569/569
(100 %)
8 diff
(98.6 %id)
BG213486   .h 836 to 1469 49 to 682   tiling clone,   634/900
(70 %)
37 diff
(95.9 %id)
CF137669 lymph .i 1 to 588 8 to 595   tiling clone,   588/597
(98 %)
9 diff
(98.5 %id)
TI_154167207   .i 1 to 640 80 to 726       647/781
(82 %)
16 diff
(98.0 %id)
CD691562 normal nasopharynx .i 65 to 599 34 to 568       535/568
(94 %)
6 diff
(99.0 %id)
CD693440 normal nasopharynx .i 65 to 657 23 to 615       593/615
(96 %)
6 diff
(99.1 %id)
CD701776 normal nasopharynx .i 65 to 660 23 to 618   tiling clone,   596/618
(96 %)
9 diff
(98.6 %id)
TI_154154942   .i 91 to 684 88 to 682   tiling clone,   595/656
(90 %)
13 diff
(98.1 %id)
AW408068 lymph .i 103 to 535 8 to 441       434/441
(98 %)
7 diff
(98.5 %id)
TI_154147394   .i 103 to 915 77 to 888 C100L A101C V103G K104Q M105N ... tiling clone,   812/858
(94 %)
70 diff
(91.9 %id)
AA485266 lung .j-u 1 to 316 1 to 314   tiling clone,   314/314
(100 %)
5 diff
(98.5 %id)
AI760555 B-cell, chronic lymphotic leukemia .j-u 314 to 794 481 to 1   tiling clone,   481/484
(99 %)
1 diff
(99.8 %id)
CR744375 Dorsal root ganglion, peripheral nervous system .j-u 364 to 816 469 to 15   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 455/455
(100 %)
2 diff
(99.6 %id)
AA291277 germinal center B cell .j-u 370 to 786 1 to 410       410/410
(100 %)
11 diff
(97.4 %id)
AW131192 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .j-u 399 to 816 421 to 1       421/421
(100 %)
4 diff
(99.1 %id)
AI369685 anaplastic oligodendroglioma, brain .j-u 422 to 809 389 to 2   tiling clone,   388/389
(99 %)
0 diff
(100 %id)
AA485267 lung .j-u 442 to 791 350 to 1       350/446
(78 %)
4 diff
(99.2 %id)
AI270186 colon, moderately-differentiated adenocarcinoma .j-u 483 to 816 336 to 1   tiling clone,   336/336
(100 %)
2 diff
(99.5 %id)
AI360360 anaplastic oligodendroglioma, brain .j-u 494 to 809 317 to 2       316/317
(99 %)
0 diff
(100 %id)
AI817261 normal prostate, Prostate .k 1 to 560 562 to 1   tiling clone,   562/562
(100 %)
7 diff
(98.8 %id)
BQ364552 stomach_normal .k 411 to 852 458 to 17   tiling clone,   442/458
(96 %)
0 diff
(100 %id)
CD707388 normal nasopharynx .k 541 to 1073 47 to 577   tiling clone,   531/577
(92 %)
7 diff
(98.8 %id)
DA948877 Spleen .k 591 to 1154 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DA937482 Spleen .k 626 to 1223 2 to 599 exact tiling clone, capped   598/598
(100 %)
1 diff
(99.9 %id)
AL712602 human skeletal muscle .l 1 to 569 1 to 569 exact tiling clone,   569/569
(100 %)
1 diff
(99.9 %id)
BC050312 Brain, hippocampus .m 1 to 3746 1 to 3745 exact tiling clone, available from MGC, AAA   3745/3745
(100 %)
5 diff
(99.9 %id)
TI_1948229618   .m 170 to 709 129 to 668   fully sequenced,   540/567
(95 %)
6 diff
(99.0 %id)
TI_1948229774   .m 170 to 709 128 to 667   fully sequenced,   540/566
(95 %)
6 diff
(99.0 %id)
TI_1948229933   .m 170 to 709 130 to 669   AAA   540/649
(83 %)
7 diff
(99.0 %id)
EL737153 mixed .m 171 to 709 1 to 539       539/540
(99 %)
8 diff
(98.6 %id)
TI_1948229619   .m 321 to 709 510 to 122   fully sequenced,   389/416
(93 %)
0 diff
(100 %id)
TI_1948229775   .m 321 to 709 513 to 125   fully sequenced,   389/416
(93 %)
0 diff
(100 %id)
BX503266 Liver .m 592 to 1085 1 to 494       494/494
(100 %)
2 diff
(99.6 %id)
AF113676 Liver .m 943 to 2019 1075 to 1   AAA Submitted on the opposite strand 1075/2571
(41 %)
8 diff
(99.7 %id)
AI064879 Liver .m 1367 to 2019 653 to 1       653/654
(99 %)
5 diff
(99.3 %id)
CN414396 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .m 2481 to 2925 1 to 445   tiling clone,   445/445
(100 %)
2 diff
(99.6 %id)
AA304655 colon .m 2773 to 3002 175 to 405       231/405
(57 %)
6 diff
(98.6 %id)
CB528759 Aveolar Macrophage, lung .m 3026 to 3773 765 to 19   AAA   747/747
(100 %)
4 diff
(99.5 %id)
BU941061 mixed (pool of 40 RNAs) .n 1 to 325 1 to 325   tiling clone,   325/897
(36 %)
4 diff
(99.6 %id)
BI019165 marrow .n 215 to 641 1 to 427   tiling clone,   427/427
(100 %)
4 diff
(99.1 %id)
AA630353 lung .o 1 to 428 434 to 6 L7S S8A Q9S R10G Q11R ... tiling clone,   429/434
(98 %)
1 diff
(99.8 %id)
AV734323 pheochromocytoma .p 1 to 712 1 to 704   tiling clone,   704/714
(98 %)
12 diff
(98.4 %id)
BF336258 colon .p 19 to 466 1 to 445       445/448
(99 %)
15 diff
(96.7 %id)
BF926019 nervous_tumor .p 50 to 555 16 to 519       504/520
(96 %)
28 diff
(94.7 %id)
AK022014 whole embryo, mainly body .p 56 to 1789 1 to 1734   tiling clone, available from FLJ,   1734/1734
(100 %)
1 diff
(100.0 %id)
AU120512 whole embryo, mainly body .p 57 to 877 2 to 820   capped   819/819
(100 %)
14 diff
(98.3 %id)
CN262127 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 663 to 1267 1 to 605       605/605
(100 %)
0 diff
(100 %id)
BG485232 lung .p 793 to 1720 1 to 952       952/971
(98 %)
67 diff
(93.1 %id)
CV353108 bladder_tumor .p 855 to 1351 3 to 495       493/495
(99 %)
6 diff
(98.8 %id)
BX282165 Kidney .p 879 to 1364 1 to 486       486/486
(100 %)
0 diff
(100 %id)
TI_151740783   .p 1168 to 1817 721 to 63       659/911
(72 %)
74 diff
(91.9 %id)
AU146556 whole embryo, mainly body .p 1261 to 1789 528 to 1       528/528
(100 %)
8 diff
(98.5 %id)
AI913577 Kidney .p 1271 to 1780 510 to 1   tiling clone,   510/510
(100 %)
0 diff
(100 %id)
AI220191 pooled .p 1285 to 1628 1 to 344     Submitted on the opposite strand 344/344
(100 %)
2 diff
(99.5 %id)
AI340197 2 pooled tumors (clear cell type), Kidney .p 1322 to 1783 462 to 1       462/462
(100 %)
1 diff
(99.8 %id)
BE825233 colon_normal .p 1336 to 1629 27 to 315       289/336
(86 %)
7 diff
(98.0 %id)
BE501406 Kidney .p 1393 to 1780 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AI934748 anaplastic oligodendroglioma, brain .p 1415 to 1837 1 to 423     Submitted on the opposite strand 423/423
(100 %)
1 diff
(99.8 %id)
BE501481 Kidney .p 1430 to 1780 351 to 1       351/351
(100 %)
0 diff
(100 %id)
BX476150   .p 1463 to 2149 1 to 686 A107T     686/686
(100 %)
5 diff
(99.3 %id)
AI300693 2 pooled tumors (clear cell type), Kidney .p 1484 to 1783 300 to 1       300/300
(100 %)
1 diff
(99.7 %id)
BX509244   .p 1512 to 2053 1 to 542 exact     542/542
(100 %)
1 diff
(99.9 %id)
CR976142 T-Lymphocytes .p 1532 to 2286 1 to 756   tiling clone,   756/756
(100 %)
4 diff
(99.5 %id)
BX481666   .p 1567 to 2214 1 to 647       647/647
(100 %)
2 diff
(99.7 %id)
BQ942501 large cell carcinoma, lung .p 1727 to 2316 48 to 648   tiling clone,   601/854
(70 %)
27 diff
(96.9 %id)
AA830474 germinal center B cell .p 1739 to 2208 11 to 477     Submitted on the opposite strand 467/467
(100 %)
3 diff
(99.4 %id)
AI217076 heart .p 1739 to 2049 1 to 311     Submitted on the opposite strand 311/311
(100 %)
0 diff
(100 %id)
BQ947467 sciatic nerve .p 1800 to 1831 8 to 39       819/902
(90 %)
18 diff
(98.1 %id)
BQ934363 epidermoid carcinoma, cell line, lung .p 1800 to 1831 9 to 40       799/906
(88 %)
16 diff
(98.3 %id)
BX952392   .q-u 1 to 513 1 to 513 exact tiling clone,   513/513
(100 %)
0 diff
(100 %id)
CD671435 eye, Iris .r-u 1 to 553 1 to 553 exact tiling clone,   553/553
(100 %)
0 diff
(100 %id)
BE925640 amnion_normal .s 1 to 379 415 to 36 V54G P56T P57T V58C L59A ... tiling clone,   380/416
(91 %)
1 diff
(99.8 %id)
BQ003227 Chondrosarcoma, Left Pelvis .s 47 to 610 581 to 19 L74V tiling clone, AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 563/563
(100 %)
3 diff
(99.5 %id)
AI888844 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .s 298 to 605 308 to 1       308/308
(100 %)
0 diff
(100 %id)
BE858577 brain, glioblastoma (pooled) .s 327 to 810 484 to 1   tiling clone,   484/484
(100 %)
0 diff
(100 %id)
BM142531 Islets of Langerhans, Pancreas .s 339 to 812 488 to 15   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 474/474
(100 %)
0 diff
(100 %id)
AI290860 carcinoid, lung .s 349 to 814 468 to 1   tiling clone,   468/468
(100 %)
2 diff
(99.6 %id)
AW029031 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .s 382 to 812 431 to 1       431/431
(100 %)
0 diff
(100 %id)
AI291014 carcinoid, lung .s 396 to 814 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AI348330 carcinoid, lung .s 414 to 814 401 to 1       401/401
(100 %)
0 diff
(100 %id)
BQ225311 epithelioid carcinoma, Pancreas .s 550 to 810 1 to 261   AAA Possibly primed on the genome, locally A rich (12/13 A in genome downstream of last aligned base) 261/261
(100 %)
0 diff
(100 %id)
AI146577 brain, glioblastoma (pooled) .s 618 to 810 193 to 1       193/193
(100 %)
0 diff
(100 %id)
AI582353 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .s 679 to 804 126 to 1       126/126
(100 %)
0 diff
(100 %id)
BE070443 breast .t 177 to 414 202 to 439 exact tiling clone,   437/439
(99 %)
6 diff
(98.7 %id)
CB961733 placenta, pre-eclamptic placenta .u 1 to 691 28 to 718 exact tiling clone, AAA   691/718
(96 %)
7 diff
(99.1 %id)
CV342077 marrow .u 239 to 487 8 to 256   tiling clone,   249/260
(95 %)
9 diff
(96.6 %id)
W21173 lung .va 1 to 272 271 to 2 G43X A55R T56R P57L V58* tiling clone, Submitted on the opposite strand 270/276
(97 %)
1 diff
(99.7 %id)
BF928241 nervous_tumor .vb 1 to 422 428 to 3 R2G R3S F20V N25S V66I tiling clone, Submitted on the opposite strand 426/430
(99 %)
5 diff
(98.9 %id)
BF928238 nervous_tumor .vb 5 to 321 13 to 329   tiling clone,   317/329
(96 %)
11 diff
(96.7 %id)
BQ334830 marrow .vb 17 to 210 193 to 2       192/193
(99 %)
2 diff
(99.0 %id)
CV406662 testis_normal .vb 221 to 637 1 to 419   tiling clone,   419/429
(97 %)
22 diff
(94.9 %id)
AI367639   .vc 1 to 385 386 to 2 exact tiling clone,   385/386
(99 %)
0 diff
(100 %id)
DA572924 whole embryo, mainly body .vd-u 1 to 847 2 to 845   tiling clone, capped   844/844
(100 %)
8 diff
(99.1 %id)
CA390859 eye, RPE/choroid .vd-u 235 to 804 22 to 594   tiling clone,   573/594
(96 %)
6 diff
(99.0 %id)
BF170918 blood .vd-u 370 to 679 1 to 310       310/310
(100 %)
8 diff
(97.5 %id)
BG570041 lung .vd-u 620 to 1483 1 to 852   tiling clone,   852/910
(93 %)
52 diff
(94.3 %id)
DB360038 whole embryo, mainly body .vd-u 1256 to 1825 567 to 1   tiling clone,   567/571
(99 %)
5 diff
(99.2 %id)
DA571182 whole embryo, mainly head .vd-u 1656 to 2515 2 to 859   tiling clone, capped   858/858
(100 %)
10 diff
(98.9 %id)
BF175635 blood .vd-u 1853 to 2166 1 to 313   tiling clone,   313/313
(100 %)
3 diff
(99.1 %id)
AK130214 pericardium .vd-u 2295 to 3232 1 to 938 exact tiling clone, available from FLJ,   938/938
(100 %)
2 diff
(99.8 %id)
DB358012 whole embryo, mainly head .vd-u 2683 to 3232 549 to 1       549/549
(100 %)
12 diff
(97.9 %id)
AI922187 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vd-u 2731 to 3232 502 to 1   tiling clone,   502/502
(100 %)
0 diff
(100 %id)
BI042351 nervous_tumor .vd-u 3203 to 3735 2 to 528   tiling clone,   527/528
(99 %)
6 diff
(98.9 %id)
BI042300 nervous_tumor .vd-u 3234 to 3765 563 to 35   tiling clone,   529/563
(93 %)
0 diff
(100 %id)
BI042263 nervous_tumor .vd-u 3258 to 3667 412 to 4   tiling clone,   409/412
(99 %)
0 diff
(100 %id)
W28753 eye, retina .vd-u 3741 to 4073 27 to 355   tiling clone,   329/490
(67 %)
9 diff
(98.2 %id)
AL133427   .ve-u 1 to 2378 1 to 2380 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2380/2380
(100 %)
8 diff
(99.7 %id)
CR748435 melanocyte .ve-u 2 to 820 1 to 821 L72P     821/821
(100 %)
5 diff
(99.4 %id)
N29023 melanocyte .ve-u 25 to 477 1 to 456       456/457
(99 %)
11 diff
(97.6 %id)
BY796731 eye .ve-u 126 to 459 1 to 334   tiling clone,   334/334
(100 %)
3 diff
(99.2 %id)
BQ354030 head_neck .ve-u 1570 to 1912 19 to 360       342/386
(88 %)
2 diff
(99.5 %id)
AA719569 pineal gland .ve-u 1586 to 1862 277 to 1       277/277
(100 %)
2 diff
(99.3 %id)
BY797751 eye .ve-u 1599 to 2037 1 to 445   tiling clone,   445/445
(100 %)
3 diff
(99.4 %id)
AW973471   .ve-u 1638 to 2377 741 to 1   tiling clone, Submitted on the opposite strand 741/741
(100 %)
13 diff
(98.3 %id)
H98167 melanocyte .ve-u 1900 to 2378 486 to 1       486/486
(100 %)
6 diff
(98.8 %id)
N20650 melanocyte .ve-u 1979 to 2378 400 to 1       400/400
(100 %)
2 diff
(99.5 %id)
N22462 cochlea, ear .ve-u 2001 to 2378 378 to 2       377/378
(99 %)
0 diff
(100 %id)
CB962805 Blood vessels - aorta, basilar and artery .ve-u 2042 to 2397 1 to 355       355/373
(95 %)
6 diff
(98.4 %id)
AA554457 colon, tumor .ve-u 2043 to 2379 336 to 1       336/336
(100 %)
7 diff
(98.0 %id)
BE834958 prostate_normal .ve-u 2282 to 2507 15 to 238       224/238
(94 %)
6 diff
(97.5 %id)
BE834914 prostate_normal .ve-u 2284 to 2507 31 to 251       221/251
(88 %)
13 diff
(94.9 %id)
BE834796 prostate_normal .ve-u 2287 to 2514 39 to 268       230/268
(85 %)
6 diff
(97.8 %id)
BE834976 prostate_normal .ve-u 2289 to 2403 1 to 116       116/117
(99 %)
6 diff
(94.9 %id)
BE834669 prostate_normal .ve-u 2292 to 2827 29 to 561       533/561
(95 %)
6 diff
(99.0 %id)
BE834670 prostate_normal .ve-u 2292 to 2532 20 to 259       240/260
(92 %)
35 diff
(86.6 %id)
BE834675 prostate_normal .ve-u 2292 to 2496 21 to 224   tiling clone,   204/234
(87 %)
33 diff
(85.9 %id)
BE834718 prostate_normal .ve-u 2292 to 2881 22 to 611       590/636
(92 %)
56 diff
(91.2 %id)
BE834866 prostate_normal .ve-u 2292 to 2827 1 to 545       545/545
(100 %)
39 diff
(92.9 %id)
BE834869 prostate_normal .ve-u 2292 to 2486 24 to 219       196/219
(89 %)
6 diff
(97.3 %id)
BE834885 prostate_normal .ve-u 2292 to 2425 30 to 164       135/164
(82 %)
6 diff
(96.4 %id)
BE834908 prostate_normal .ve-u 2292 to 2528 21 to 258       238/262
(90 %)
29 diff
(89.0 %id)
BE834919 prostate_normal .ve-u 2292 to 2554 31 to 292   tiling clone,   262/292
(89 %)
8 diff
(97.3 %id)
BE834965 prostate_normal .ve-u 2292 to 2850 11 to 573       563/573
(98 %)
60 diff
(89.6 %id)
BE834973 prostate_normal .ve-u 2292 to 2815 35 to 563       529/567
(93 %)
72 diff
(87.4 %id)
BE834974 prostate_normal .ve-u 2292 to 2823 12 to 555       544/555
(98 %)
6 diff
(99.0 %id)
BE834978 prostate_normal .ve-u 2292 to 2528 8 to 246       239/250
(95 %)
6 diff
(97.6 %id)
BE834916 prostate_normal .ve-u 2293 to 2848 1 to 557       557/560
(99 %)
63 diff
(88.8 %id)
BE834943 prostate_normal .ve-u 2321 to 2874 552 to 1       552/552
(100 %)
14 diff
(97.5 %id)
BF369948 prostate_normal .ve-u 2327 to 2886 559 to 1   tiling clone,   559/572
(97 %)
23 diff
(96.0 %id)
BF369962 prostate_normal .ve-u 2329 to 2886 558 to 2   tiling clone,   557/558
(99 %)
0 diff
(100 %id)
BF369943 prostate_normal .ve-u 2336 to 2873 568 to 30       539/572
(94 %)
0 diff
(100 %id)
BF369961 prostate_normal .ve-u 2369 to 2872 506 to 2       505/506
(99 %)
0 diff
(100 %id)
BF369946 prostate_normal .ve-u 2381 to 2866 504 to 19   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 486/486
(100 %)
4 diff
(99.2 %id)
BF369956 prostate_normal .ve-u 2383 to 2873 496 to 4       493/529
(93 %)
0 diff
(100 %id)
CA395556 eye, RPE/choroid .vf-u 1 to 654 1 to 654 exact tiling clone,   654/654
(100 %)
0 diff
(100 %id)
DB171845 kidney, tumor tissue .vf-u 337 to 915 2 to 581   tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
GD153480   .vf-u 436 to 670 238 to 1     Submitted on the opposite strand 238/241
(98 %)
3 diff
(98.8 %id)
AI821139 lung .vg-u 1 to 470 1 to 470 exact tiling clone,   470/470
(100 %)
0 diff
(100 %id)
FN063975 breast carcinoma .vg-u 188 to 302 115 to 1     Submitted on the opposite strand 115/115
(100 %)
0 diff
(100 %id)
AI791153 lung .vg-u 201 to 698 498 to 1       498/498
(100 %)
1 diff
(99.8 %id)
AI732110 lung .vg-u 271 to 698 428 to 1   tiling clone,   428/428
(100 %)
0 diff
(100 %id)
AA634036 lung .vg-u 385 to 696 314 to 1       314/362
(86 %)
11 diff
(97.0 %id)
AA634016 lung .vg-u 408 to 698 291 to 1       291/291
(100 %)
2 diff
(99.4 %id)
CD697272 normal nasopharynx .vh 1 to 643 24 to 666 P2Y W4R S5G C15G S23G ... tiling clone,   643/666
(96 %)
15 diff
(97.8 %id)
DB223680 trachea .vi 1 to 557 2 to 558   tiling clone, capped   557/557
(100 %)
1 diff
(99.9 %id)
DB233781 trachea .vi 63 to 519 2 to 459   capped   458/458
(100 %)
1 diff
(99.8 %id)
BE816282 breast_normal .vj-u 1 to 506 508 to 5 L10W I17M tiling clone,   504/508
(99 %)
0 diff
(100 %id)
BF358497 lung_normal .vj-u 136 to 451 32 to 348       317/357
(88 %)
4 diff
(98.9 %id)
BX484710   .vk-u 1 to 497 1 to 497 exact tiling clone,   497/497
(100 %)
0 diff
(100 %id)
AW752991 colon .vl-u 1 to 449 15 to 462 C7V V9S T10L F11S H12I ... tiling clone,   448/462
(96 %)
6 diff
(98.8 %id)
AV726933 hypothalamus .vm-u 1 to 395 1 to 395 exact tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 395/395
(100 %)
0 diff
(100 %id)
AU185378 skin .vm-u 90 to 329 240 to 1       240/240
(100 %)
0 diff
(100 %id)
DB220547 trachea .vn-u 1 to 320 2 to 321 exact tiling clone, capped   320/320
(100 %)
0 diff
(100 %id)
AV750666 Pituitary .vo-u 1 to 284 1 to 277 L23X C43X V47X E55V N56L ... tiling clone,   277/281
(98 %)
9 diff
(96.8 %id)
305 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m, .n, .o, .p, .q-u, .r-u, .s, .t, .u, .va, .vb, .vc, .vd-u, .ve-u, .vf-u, .vg-u, .vh, .vi, .vj-u, .vk-u, .vl-u, .vm-u, .vn-u, .vo-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI